$94 M

Immucor Revenue Q3, 2017
Immucor Gross profit (Q3, 2017)94 M
Immucor Gross profit margin (Q3, 2017), %100%
Immucor Net income (Q3, 2017)-32.3 M
Immucor EBIT (Q3, 2017)8.1 M
Immucor Cash, 28-Feb-201710 M

Immucor Funding

Summary Metrics

Founding Date

1982

Immucor investors

Immucor Income Statement

Annual

USDFY, 2016

Revenue

380.0m

Cost of goods sold

144.0m

Gross profit

236.0m

Gross profit Margin, %

62%

R&D expense

30.3m

General and administrative expense

44.5m

Operating expense total

74.7m

EBIT

28.9m

EBIT margin, %

8%

Interest expense

90.5m

Interest income

135.0k

Pre tax profit

(61.7m)

Income tax expense

(18.0m)

Net Income

(43.8m)

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

102.4m96.3m95.6m96.7m96.2m88.9m98.6m93.7m94.0m

Cost of goods sold

36.8m35.8m34.0m34.6m37.9m34.1m38.2m

Gross profit

65.6m60.5m61.6m62.1m58.4m54.8m98.6m55.5m94.0m

Gross profit Margin, %

64%63%64%64%61%62%100%59%100%

R&D expense

7.1m7.1m7.3m6.8m6.8m6.9m9.0m8.8m8.8m

General and administrative expense

10.9m10.7m9.4m10.7m10.6m11.8m11.6m10.5m10.0m

Operating expense total

18.0m17.8m16.6m17.6m17.4m18.7m20.5m19.3m18.9m

EBIT

13.9m8.4m12.9m12.5m8.2m5.1m8.2m2.2m8.1m

EBIT margin, %

14%9%13%13%9%6%8%2%9%

Interest expense

22.3m22.8m21.8m22.5m22.5m22.3m23.1m23.1m23.0m

Interest income

56.0k32.0k42.0k42.0k41.0k48.0k6.0k8.0k1.0k

Pre tax profit

(8.3m)(14.2m)(8.7m)(10.1m)(14.1m)(17.5m)(15.5m)(20.9m)(15.0m)

Income tax expense

(2.8m)(5.1m)(2.8m)(2.4m)(8.8m)(5.4m)(8.1m)(5.6m)

Net Income

(5.5m)(14.6m)(54.0m)(7.2m)(19.0m)(27.7m)(10.1m)(22.9m)(32.3m)

Immucor Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016

Cash

23.6m18.4m10.3m

Accounts Receivable

62.0m

Inventories

49.2m11.2m46.9m

Current Assets

163.2m145.0m127.7m

PP&E

76.3m73.6m76.0m

Goodwill

851.6m842.3m857.0m

Total Assets

1.8b1.8b1.7b

Accounts Payable

15.7m13.9m22.2m

Short-term debt

6.8m

Current Liabilities

71.3m70.0m75.4m

Total Debt

6.8m

Total Liabilities

1.4b

Additional Paid-in Capital

753.1m755.2m753.7m

Retained Earnings

(271.3m)(332.0m)(374.1m)

Total Equity

468.6m383.7m344.5m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

3.9 x4.6 x5 x

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

19.0m15.1m12.2m9.7m10.5m10.0m

Inventories

48.5m44.7m47.8m49.3m47.3m48.9m

Current Assets

149.3m140.6m135.8m133.2m125.3m131.9m

PP&E

73.3m72.2m72.8m75.9m76.3m76.8m

Goodwill

842.3m840.5m840.8m856.7m854.4m854.7m

Total Assets

1.7b1.7b1.7b1.7b1.7b1.7b

Accounts Payable

16.0m13.7m17.6m18.0m17.4m21.3m

Short-term debt

27.8m16.7m26.7m

Current Liabilities

69.9m60.8m59.5m79.7m80.7m85.9m

Additional Paid-in Capital

756.1m758.0m753.3m754.6m752.2m750.0m

Retained Earnings

(339.2m)(351.0m)(359.4m)(382.7m)(394.0m)(401.7m)

Total Equity

377.4m362.1m356.6m336.1m317.9m310.4m

Financial Leverage

4.6 x4.7 x4.8 x5.1 x5.3 x5.4 x

Immucor Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016

Net Income

(6.4m)(60.7m)(43.8m)

Depreciation and Amortization

50.8m50.8m54.9m

Inventories

(3.1m)(12.0m)

Accounts Payable

(1.4m)8.3m

Cash From Operating Activities

25.6m27.1m

Purchases of PP&E

(11.4m)(9.9m)

Long-term Borrowings

(6.7m)(6.7m)

Interest Paid

79.2m78.8m

Income Taxes Paid

111.0k(160.0k)

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(5.5m)(14.6m)(54.0m)(7.2m)(19.0m)(27.7m)(10.1m)(22.9m)(32.3m)

Depreciation and Amortization

18.4m36.1m53.8m17.0m34.2m51.4m18.2m36.2m54.1m

Inventories

(1.8m)(2.4m)(6.0m)(7.9m)(6.2m)(11.0m)(3.9m)(4.1m)(8.3m)

Accounts Payable

2.1m2.7m(3.3m)2.2m(187.0k)4.2m(4.1m)(4.3m)(779.0k)

Cash From Operating Activities

15.0m2.8m8.0m6.8m974.0k

Purchases of PP&E

(3.3m)(6.9m)(7.5m)(2.0m)(3.9m)(7.0m)(2.8m)(6.9m)(8.2m)

Long-term Borrowings

(1.7m)(3.3m)(5.0m)(1.7m)(3.3m)(5.0m)(1.7m)(3.4m)(5.1m)

Dividends Paid

(4.5m)(7.7m)

Cash From Financing Activities

19.3m

Interest Paid

30.5m39.7m70.7m30.8m39.5m70.3m30.7m39.3m69.9m

Income Taxes Paid

71.0k(25.0k)526.0k300.0k(309.0k)(495.0k)481.0k988.0k695.0k

Immucor Ratios

USDY, 2017

Revenue/Employee

107.8k

Financial Leverage

5.4 x
Report incorrect company information